Domestic News
1. GE Healthcare Japan Unveils State-of-the-Art Photon-Counting CT for the First Time in Japan
【New Products/Technological Innovations】
GE Healthcare Japan Corporation unveiled its latest model of photon-counting CT (PCCT), a next-generation diagnostic imaging technology, for the first time in Japan at "ITEM2026 (International Technical Exhibition of Medical Imaging)" held from April 17 to 19, 2026.
Impact on the Industry: PCCT is an innovative technology that achieves overwhelmingly higher resolution and lower radiation exposure than conventional CT. With Canon Medical Systems having already announced its launch, GE Healthcare's entry is expected to further intensify competition in the domestic high-end CT market.
2. "Medtec Japan 2026" Opens Tomorrow, Showcasing the Forefront of Medical Device Design and Manufacturing
【Events/Industry Trends】
"Medtec Japan 2026," Japan's largest exhibition specializing in medical device design and manufacturing, will be held at Tokyo Big Sight from April 21 to 23, 2026. This year, particular attention is being paid to support for SaMD (Software as a Medical Device) development and AI-powered quality control solutions.
Impact on the Industry: The exhibition features a wide range of exhibits supporting the "streamlining of development" for medical device manufacturers, including the utilization of digital twins in manufacturing processes and design consulting services compliant with the latest PMDA regulations. It will serve as an important venue for information exchange for domestic manufacturers aiming to strengthen their supply chains.
International News
3. Abbott Announces Q1 2026 Financial Results: Medical Devices Drive Growth
【Financial Performance and Business Strategy】
Abbott announced its first-quarter financial results on April 16, 2026. While the full-year earnings outlook was revised downward due to the acquisition of Exact Sciences ($21 billion), sales in the medical devices division maintained strong year-over-year growth.
Impact on the Industry: Diabetes management devices (FreeStyle Libre) and cardiovascular products continue to perform well. Despite temporary cost increases from a major acquisition, Abbott's strategy of expanding market share in both diagnostics and devices is a trend that other major medtech companies should closely monitor.
4. Israel's MeMed Receives FDA Breakthrough Device Designation for Infection Differentiation Device
【Regulatory Trends and New Products】
Israel-based MeMed announced that its unique immune biomarker technology, which differentiates between viral and bacterial infections in minutes, has received
Featured Topic: AI Implementation in the Gastrointestinal Endoscopy Field
At current exhibitions and similar events, the evolution of gastrointestinal endoscopy AI from "automatic interpretation assistance" to "automatic measurement and classification of lesions" is remarkable. Implementation of technology that allows AI to quantify lesion size and invasiveness, not merely detect abnormalities, is progressing. This advancement will reduce variability due to physician subjectivity and enable the accumulation of more objective diagnostic data.
References
- GE Healthcare Japan: ITEM2026 Exhibition Overview: Display of Next-Generation Photon Counting CT
- Medtec Japan Secretariat: Medtec Japan 2026 Pre-Event Press Release
- Abbott: Abbott Reports First-Quarter 2026 Results
- MeMed: MeMed Receives FDA Breakthrough Device Designation for Infection Discrimination Technology
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation